2VSA.F
Price:
$8.95
Market Cap:
$627.18M
Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of avutometinib and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 202...[Read more]
Industry
Biotechnology
IPO Date
2012-02-13
Stock Exchange
FSX
Ticker
2VSA.F
According to Verastem, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 547.57M. This represents a change of 293.82% compared to the average of 139.04M of the last 4 quarters.
The mean historical Enterprise Value of Verastem, Inc. over the last ten years is 133.44M. The current 547.57M Enterprise Value has changed 40.93% with respect to the historical average. Over the past ten years (40 quarters), 2VSA.F's Enterprise Value was at its highest in in the June 2021 quarter at 698.56M. The Enterprise Value was at its lowest in in the June 2023 quarter at -8664920.00.
Average
133.44M
Median
140.16M
Minimum
-43424487.44
Maximum
339.46M
Discovering the peaks and valleys of Verastem, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 457.50%
Maximum Annual Enterprise Value = 339.46M
Minimum Annual Increase = -121.50%
Minimum Annual Enterprise Value = -43424487.44
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 138.07M | -2.93% |
| 2023 | 142.24M | 380.65% |
| 2022 | 29.59M | -91.28% |
| 2021 | 339.46M | 20.65% |
| 2020 | 281.35M | 71.61% |
| 2019 | 163.95M | -26.64% |
| 2018 | 223.50M | 341.64% |
| 2017 | 50.61M | 457.50% |
| 2016 | 9.08M | -120.90% |
| 2015 | -43424487.44 | -121.50% |
The current Enterprise Value of Verastem, Inc. (2VSA.F) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
103.30M
5-year avg
186.14M
10-year avg
133.44M
Verastem, Inc.’s Enterprise Value is greater than Formycon AG (423.65M), greater than Zura Bio Limited (104.17M), greater than Heidelberg Pharma AG (99.27M), greater than 4basebio PLC (99.65M), greater than Medios AG (486.16M), greater than Stratec SE (388.38M), greater than BRAIN Biotech AG (55.67M), greater than Newron Pharmaceuticals S.p.A. (415.97M), greater than M1 Kliniken AG (315.10M), less than CureVac N.V. (633.43M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 423.65M | $440.73M | |
| 104.17M | $214.57M | |
| 99.27M | $132.40M | |
| 99.65M | $123.10M | |
| 486.16M | $369.32M | |
| 388.38M | $278.37M | |
| 55.67M | $66.20M | |
| 415.97M | $387.64M | |
| 315.10M | $338.76M | |
| 633.43M | $986.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verastem, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Verastem, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Verastem, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Verastem, Inc. (2VSA.F)?
What is the 3-year average Enterprise Value for Verastem, Inc. (2VSA.F)?
What is the 5-year average Enterprise Value for Verastem, Inc. (2VSA.F)?
How does the current Enterprise Value for Verastem, Inc. (2VSA.F) compare to its historical average?